Galapagos NV [GLPGA] vs Vivoryon [VVY] Detailed Stock Comparison
Galapagos NV
Euronext
Loading...
Vivoryon
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Galapagos NV wins in 8 metrics, Vivoryon wins in 7 metrics, with 0 ties. Galapagos NV appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Galapagos NV | Vivoryon | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 51.71 | -1.77 | Vivoryon |
| Price-to-Book Ratio | 0.71 | 4.63 | Galapagos NV |
| Debt-to-Equity Ratio | 0.32 | 1.29 | Galapagos NV |
| PEG Ratio | -40.71 | -1.86 | Galapagos NV |
| EV/EBITDA | 4.39 | -1.30 | Vivoryon |
| Profit Margin (TTM) | -103.14% | 0.00% | Vivoryon |
| Operating Margin (TTM) | -87.35% | 0.00% | Vivoryon |
| Return on Equity | -10.39% | -120.41% | Galapagos NV |
| Return on Assets (TTM) | -5.11% | -62.22% | Galapagos NV |
| Free Cash Flow (TTM) | $-402.14M | $-19.18M | Vivoryon |
| 1-Year Return | 21.85% | -32.08% | Galapagos NV |
| Price-to-Sales Ratio (TTM) | 6.81 | N/A | N/A |
| Enterprise Value | $-1.23B | $27.16M | Vivoryon |
| EV/Revenue Ratio | -4.45 | N/A | N/A |
| Gross Profit Margin (TTM) | 92.79% | N/A | N/A |
| Revenue per Share (TTM) | $4 | $0 | Galapagos NV |
| Earnings per Share (Diluted) | $-4.38 | $-0.79 | Vivoryon |
| Beta (Stock Volatility) | -0.05 | 1.96 | Galapagos NV |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Galapagos NV vs Vivoryon Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Galapagos NV | -0.57% | -0.28% | 13.36% | 24.11% | 27.74% | 1.97% |
| Vivoryon | 0.98% | 2.86% | -1.37% | -18.18% | -26.15% | -31.43% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Galapagos NV | 21.85% | -47.55% | -82.27% | -48.43% | 477.32% | 254.43% |
| Vivoryon | -32.08% | -82.04% | -73.18% | -93.09% | -92.66% | -92.66% |
Performance & Financial Health Analysis: Galapagos NV vs Vivoryon
| Metric | GLPGA | VVY |
|---|---|---|
| Market Information | ||
| Market Cap | €1.88B | €36.91M |
| Market Cap Category | Large cap | Small cap |
| 10 Day Avg. Volume | 175,991 | 25,989 |
| 90 Day Avg. Volume | 167,462 | 39,085 |
| Last Close | €28.00 | €1.44 |
| 52 Week Range | €20.00 - €31.08 | €1.37 - €2.99 |
| % from 52W High | -9.91% | -51.79% |
| All-Time High | €252.90 (Feb 17, 2020) | €27.19 (Jan 11, 2016) |
| % from All-Time High | -88.93% | -94.70% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.16% | N/A |
| Quarterly Earnings Growth | -0.16% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -1.03% | 0.00% |
| Operating Margin (TTM) | -0.87% | 0.00% |
| Return on Equity (TTM) | -0.10% | -1.20% |
| Debt to Equity (MRQ) | 0.32 | 1.29 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €40.12 | €0.30 |
| Cash per Share (MRQ) | €46.91 | €0.36 |
| Operating Cash Flow (TTM) | €-278,547,008 | €-19,174,000 |
| Levered Free Cash Flow (TTM) | €-33,690,752 | €-12,064,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Galapagos NV vs Vivoryon
| Metric | GLPGA | VVY |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 51.71 | -1.77 |
| Forward P/E | -40.71 | -1.86 |
| PEG Ratio | -40.71 | -1.86 |
| Price to Sales (TTM) | 6.81 | N/A |
| Price to Book (MRQ) | 0.71 | 4.63 |
| Market Capitalization | ||
| Market Capitalization | €1.88B | €36.91M |
| Enterprise Value | €-1,227,399,424 | €27.16M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -4.45 | N/A |
| Enterprise to EBITDA | 4.39 | -1.30 |
| Risk & Other Metrics | ||
| Beta | -0.05 | 1.96 |
| Book Value per Share (MRQ) | €40.12 | €0.30 |
Financial Statements Comparison: Galapagos NV vs Vivoryon
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GLPGA | VVY |
|---|---|---|
| Revenue/Sales | €65.29M | N/A |
| Cost of Goods Sold | €4.71M | N/A |
| Gross Profit | €60.58M | N/A |
| Research & Development | €95.28M | N/A |
| Operating Income (EBIT) | €-57.03M | N/A |
| EBITDA | €-44.29M | N/A |
| Pre-Tax Income | €-104.42M | N/A |
| Income Tax | €26,000 | N/A |
| Net Income (Profit) | €-105.75M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GLPGA | VVY |
|---|---|---|
| Cash & Equivalents | €108.07M | €9.37M |
| Total Current Assets | €3.47B | €10.07M |
| Total Current Liabilities | €437.04M | €1.40M |
| Long-Term Debt | €7.79M | €42,000 |
| Total Shareholders Equity | €2.75B | €7.88M |
| Retained Earnings | €-280.81M | €-169.37M |
| Property, Plant & Equipment | N/A | €124,000 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GLPGA | VVY |
|---|---|---|
| Operating Cash Flow | €-42.99M | N/A |
| Capital Expenditures | €-5.10M | N/A |
| Free Cash Flow | €-43.86M | N/A |
| Debt Repayment | €-1.01M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GLPGA | VVY |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 175,991 | 25,989 |
| Average Daily Volume (90 Day) | 167,462 | 39,085 |
| Shares Outstanding | 65.90M | 26.07M |
| Float Shares | 65.05M | 21.35M |
| % Held by Insiders | 0.25% | 0.25% |
| % Held by Institutions | 0.32% | 0.07% |
Dividend Analysis & Yield Comparison: Galapagos NV vs Vivoryon
| Metric | GLPGA | VVY |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |